Investegate |GenMark Diagnostics, Inc. Announcements | GenMark Diagnostics, Inc.: Study Highlights Potential Clinical Value of ePlex® Blood Culture ID Panels
Study Highlights Potential Clinical Value of ePlex® Blood Culture ID Panels Major teaching hospital in Grenoble, France demonstrates that ePlex BCID results could have modified antimicrobial treatment in 45% of patients CARLSBAD, Calif., Feb. 16, 2021 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, announced today the publication of a manuscript in Frontiers in Cellular and Infection Microbiology that highlights strong performance and the potential clinical impact of the ePlex Blood Culture Ident...
Source: investegate.co.uk